Jennifer Jarrett - Aug 15, 2022 Form 4 Insider Report for Radius Health, Inc. (RDUS)

Role: Director
Signature: /s/ Kim Clarke, as attorney-in-fact
Stock symbol: RDUS
Transactions as of: Aug 15, 2022
Transactions value $: -$124,800
Form type: 4
Date filed: 8/15/2022, 04:16 PM
Previous filing: Jun 21, 2022
Next filing: Sep 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RDUS	Stock Option (Right to Buy)	Disposed to Issuer	-$125K	-30K	-100%	$4.16	0	Aug 15, 2022	Common Stock	30K	$5.84	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jennifer Jarrett is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Pursuant to the Merger Agreement, at the Effective Time, these options automatically vested and were cancelled, by virtue of the Merger and without any action on the part of the Reporting Person, and the Reporting Person was entitled to receive (without interest) (A) an amount in cash (less applicable Tax withholdings) equal to the product of (x) the total number of Shares subject to such option immediately prior to the effective time multiplied by (y) the excess, if any, of the Cash Consideration over the applicable exercise price per Share under such option, and (B) one CVR for each Share subject thereto.

Content

Pursuant to the Merger Agreement, at the Effective Time, these options automatically vested and were cancelled, by virtue of the Merger and without any action on the part of the Reporting Person, and the Reporting Person was entitled to receive (without interest) (A) an amount in cash (less applicable Tax withholdings) equal to the product of (x) the total number of Shares subject to such option immediately prior to the effective time multiplied by (y) the excess, if any, of the Cash Consideration over the applicable exercise price per Share under such option, and (B) one CVR for each Share subject thereto.

Remarks:

Capitalized terms used herein without definition have the meanings ascribed to them in the Agreement and Plan of Merger, dated as of June 23, 2022, by and among Ginger Acquisition, Inc., Ginger Merger Sub, Inc. and Radius Health, Inc. (the "Merger Agreement").